首页 | 本学科首页   官方微博 | 高级检索  
     

慢性乙型肝炎及肝炎肝硬化患者sICAM-1水平临床观察
引用本文:张艳兰,李群,周宁. 慢性乙型肝炎及肝炎肝硬化患者sICAM-1水平临床观察[J]. 湖北民族学院学报(医学版 ), 2010, 27(1): 24-26
作者姓名:张艳兰  李群  周宁
作者单位:潍坊医学院传染病学教研室,山东,潍坊,261042;潍坊医学院传染病学教研室,山东,潍坊,261042;潍坊医学院传染病学教研室,山东,潍坊,261042
摘    要:目的探讨慢性乙型肝炎(简称慢性乙肝)、肝炎肝硬化患者血清中可溶性细胞间粘附分子-1(sICAM-1)的表达水平及其临床意义。方法采用酶联免疫吸附分析(ELISA)法,测定10例健康对照人群、41例门诊及病区就诊患者的sICAM-1血清含量,其中慢性乙肝30例,肝炎肝硬化11例。结果与正常对照组相比,慢性乙肝患者和肝炎肝硬化患者血清中sICAM-1含量均显著增加(P〈0.01)。结论sICAM-1水平可作为评价肝细胞损害程度及肝纤维化程度的指标之一,并可能在肝炎及肝硬化的发病机制中发挥重要作用。

关 键 词:细胞间粘附分子-1  慢性乙肝  肝炎肝硬化

Clinical Study on sICAM-1 Level in the Serum of Chronic Hepatitis B and Liver Cirrhosis after Hepatitis
ZHANG Yan-lan,LI Qun,ZHOU Ning. Clinical Study on sICAM-1 Level in the Serum of Chronic Hepatitis B and Liver Cirrhosis after Hepatitis[J]. Journal of Hubei Institute For Nationalities(Medical Edition), 2010, 27(1): 24-26
Authors:ZHANG Yan-lan  LI Qun  ZHOU Ning
Affiliation:( Department of Epidemiology, Weifang Medical College, Weifang 261042, China )
Abstract:Objective To explore the serum slCAM-1 level in chronic hepatitis B and liver cirrhosis after hepatitis and its clinical significance. Methods The serum sICAM-1 of 10 healthy persons as control and 41 patients was detected by enzyme- linked immunosorbent assay (ELISA). Resets The level of slCAM-1 in 30 CH and 11 LC was significantly higher than healthy persons as control(P〈0. 01). Conclusions The serum sICAM-1 level of patents with CH and LC is useful for the determination of the severity of liver disease and fibrosisi, sICAM-1 may play an important role in the the study of pathogenesis of liver diseae.
Keywords:sICAM-1  chronic hepatitis B  liver cirrhosis
本文献已被 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号